Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely

Biochem J. 1992 Feb 15;282 ( Pt 1)(Pt 1):129-37. doi: 10.1042/bj2820129.

Abstract

A binding domain for Factor VIII (F.VIII) has been previously identified on the N-terminal portion of human von Willebrand Factor (vWF) subunit [amino acids (AA) 1-272]. In order to characterize other possible structures of vWF involved in its capacity to bind and to protect F.VIII against human activated protein C (APC), we used a series of purified vWF fragments overlapping the whole sequence of the subunit. Among those were fragments SpIII (dimer; AA 1-1365), SpII (dimer; AA 1366-2050) and SpI (monomer; AA 911-1365) generated by Staphylococcus aureus V8 proteinase, a P34 species (monomer; AA 1-272) obtained with plasmin, a monomeric 39/34 kDa dispase fragment (AA 480-718) and a tetrameric III-T2 fragment (AA 273-511/674-728) produced from SpIII by trypsin. Three other fragments without precise extremities were located using selected monoclonal antibodies to vWF. Two C-terminal fragments of 270 and 260 kDa, overlapping SpI and SpII, were respectively generated from vWF with trypsin and protease 1 from Crotalus atrox venom. An N-terminal 120 kDa fragment, overlapping P34 and 39/34 kDa fragments, was produced by protease 1. Our results show that vWF bound to F.VIII and protected it from degradation by APC in a dose-dependent way. Among the C-terminal and central vWF fragments (SpII, tryptic 270 kDa, 260 kDa, SpI, 39/34 kDa and III-T2), none had the capacity to bind or to protect F.VIII, even at high concentrations. The three N-terminal fragments (SpIII, 120 kDa and P34) bound to F.VIII in a dose-dependent and saturable fashion. SpIII and the 120 kDa fragment had the capacity to protect F.VIII in a dose-dependent way. In contrast, the P34 species did not significantly protect F.VIII, even when using high concentrations of the fragment. In conclusion, the N-terminal end of vWF subunit (AA 1-272) plays a crucial role in binding to F.VIII, but requires additional structures of the 120 kDa fragment to protect it against APC. In addition, the presence of a secondary binding and/or protecting domain on other portions of the vWF subunit (potentially destroyed during the proteolysis of vWF) is highly unlikely.

MeSH terms

  • Antibodies
  • Antibodies, Monoclonal
  • Binding Sites
  • Electrophoresis, Polyacrylamide Gel
  • Endopeptidases / metabolism
  • Factor VIII / metabolism*
  • Fibrinolysin / metabolism
  • Humans
  • Immunosorbent Techniques
  • Macromolecular Substances
  • Peptide Fragments / isolation & purification
  • Peptide Fragments / metabolism
  • Trypsin / metabolism
  • von Willebrand Factor / chemistry
  • von Willebrand Factor / isolation & purification
  • von Willebrand Factor / metabolism*

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Macromolecular Substances
  • Peptide Fragments
  • von Willebrand Factor
  • Factor VIII
  • Endopeptidases
  • Trypsin
  • Fibrinolysin
  • dispase